SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-048289
Filing Date
2024-04-25
Accepted
2024-04-25 16:05:53
Documents
6
Period of Report
2024-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A tern-def14a-2024.htm DEF 14A 792415
2 GRAPHIC img192746612_0.jpg GRAPHIC 659680
3 GRAPHIC img192746612_1.jpg GRAPHIC 659680
4 GRAPHIC img192746612_2.jpg GRAPHIC 659680
5 GRAPHIC img192746612_3.jpg GRAPHIC 219741
6 GRAPHIC img192746612_4.jpg GRAPHIC 246264
  Complete submission text file 0000950170-24-048289.txt   4156910
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39926 | Film No.: 24876229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)